Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

3.8K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
3.8K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

3.0K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
3.0K
Tissue Transplantation01:24

Tissue Transplantation

1.4K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transplantation of unrelated placental blood cells in children with high-risk sickle cell disease.

Bone marrow transplantation·2004
Same author

Allogeneic hematopoietic cell transplantation for inborn metabolic diseases.

Annals of hematology·2003
Same author

Generation of alloreactive anti-leukemic cytotoxic T lymphocytes with attenuated GVHD properties from haploidentical parents in childhood acute lymphoblastic leukemia.

Bone marrow transplantation·2002
Same author

Viability of cryopreserved BM progenitor cells stored for more than a decade.

Cytotherapy·2002
Same author

Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2002
Same author

Phenylbutyrate attenuates the expression of Bcl-X(L), DNA-PK, caveolin-1, and VEGF in prostate cancer cells.

Neoplasia (New York, N.Y.)·2001

Related Experiment Video

Updated: May 5, 2026

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

17.2K

Autologous bone marrow transplantation.

G W Santos1, A M Yeager, R J Jones

  • 1Oncology Center, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.

Annual Review of Medicine
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Autologous bone marrow transplantation provides a curative option for acute leukemias and lymphomas when an allogeneic donor is unavailable. This approach shows promising survival rates, particularly in lymphoma patients, and research is expanding to other cancers.

More Related Videos

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

7.3K
Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

12.9K

Related Experiment Videos

Last Updated: May 5, 2026

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

17.2K
Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

7.3K
Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

12.9K

Area of Science:

  • Hematology
  • Oncology
  • Transplantation Medicine

Background:

  • Autologous bone marrow transplantation (ABMT) is a critical therapeutic option for patients with hematological malignancies lacking a suitable allogeneic donor.
  • It offers a potentially curative treatment pathway for acute leukemias and lymphomas.
  • The use of ex vivo purging of autologous marrow remains a subject of ongoing investigation and debate among researchers.

Purpose of the Study:

  • To evaluate the efficacy of autologous bone marrow transplantation in treating acute leukemias and lymphomas.
  • To discuss the role and necessity of ex vivo purging in eradicating residual tumor cells.
  • To explore the potential of ABMT in other malignancies, including multiple myeloma and solid tumors.

Main Methods:

  • Review of outcomes for patients undergoing autologous bone marrow transplantation for lymphomas and acute leukemias.
  • Discussion of the controversial technique of ex vivo purging of bone marrow.
  • Analysis of preliminary data from ABMT studies in multiple myeloma and various solid tumors.

Main Results:

  • Disease-free survival rates of 50-60% are observed in lymphoma patients post-ABMT, especially those with refractory disease.
  • Relapse-free survival expectations range from 20-40% for acute leukemia patients treated with ABMT.
  • Preliminary studies indicate promising results for ABMT in multiple myeloma and certain pediatric cancers.

Conclusions:

  • Autologous bone marrow transplantation is a viable and potentially curative treatment for acute leukemias and lymphomas when allogeneic options are exhausted.
  • The efficacy of ex vivo purging requires further validation but is considered essential by some for optimal outcomes.
  • ABMT is an evolving therapeutic strategy with expanding applications in various hematological and solid malignancies.